Clinicopathological analysis and prognostic factors of 11 patients with primary non‑Hodgkin lymphoma of the small intestine in a single institute

Chen,Jia‑Hong; Ho,Ching‑Liang; Chen,Yeu‑Chin; Chao,Tsu‑Yi; Kao,Woei‑Yau

doi:10.3892/ol.2014.2209

August-2014 Volume 8 Issue 2

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

August-2014 Volume 8 Issue 2

Full Size Image

Article

Clinicopathological analysis and prognostic factors of 11 patients with primary non‑Hodgkin lymphoma of the small intestine in a single institute

Authors:
- Jia‑Hong Chen
- Ching‑Liang Ho
- Yeu‑Chin Chen
- Tsu‑Yi Chao
- Woei‑Yau Kao
View Affiliations / Copyright

Affiliations: Division of Hematology/Oncology, Department of Medicine, Tri‑Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan, R.O.C.
Pages: 876-880
|
Published online on: June 2, 2014

https://doi.org/10.3892/ol.2014.2209
Expand metrics +

Abstract

The gastrointestinal (GI) tract is the most common extranodal site of involvement in non‑Hodgkin lymphoma (NHL). Primary GI NHL is frequently discussed in survival analyses. Primary intestinal NHL is significantly different from primary gastric NHL with regard to its clinical features, pathological subtype, treatment and prognosis. The small intestine is involved in lymphoma less often than the large intestine. The present study aimed to analyze the clinical and pathological characteristics of primary NHL of the small intestine and its prognostic factors. A retrospective analysis was performed on clinical data from 313 cases of NHL that occurred between 1995 and 2008 in the Tri‑Service General Hospital (National Defense Medical Center, Taipei, Taiwan). Among these cases, 11 cases of primary NHL of the small intestine were identified. A Cox model was used to perform the multivariate analysis. The Kaplan‑Meier method was used for the survival analysis. From the 11 patients with primary NHL of the small intestine, seven patients were male (63.6%) and four patients were female (36.3%). Furthermore, nine patients (81.8%) were diagnosed with B‑cell lymphoma, of which five (45.5%) were also diagnosed with diffuse large B‑cell lymphoma (DLBL). Abdominal pain and/or distention were present in six (54.5%) of the patients and jejunum involvement was also observed in six (54.5%) of the 11 patients. The mean overall survival (OS) time of the 11 patients was 27.2 months and the four‑year survival rate was 36.3%. The mean OS time in the patients with jejunum involvement was shorter than in those without jejunum involvement (16.9 vs. 39.6 months), although this difference was not significant (P=0.657). Surgical treatment was performed on four of the six patients with jejunum involvement due to an acute abdomen or perforation‑related peritonitis. The results of the present study indicate that DLBL is the most common subtype of primary lymphoma of the small intestine, and that the site involved in NHL may affect the potential for surgery in patients with intestinal lymphoma. Furthermore, patients with primary lymphoma of the small intestine have been found to have a poor outcome compared with those with lymphoma in other regions of the GI tract. In the present study, a similar trend was observed, however, the sizes of the subgroups of primary lymphoma of the small intestine were too small for individual analysis.

View Figures

View References

1	Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H and Jaffe ES: The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 117:5019–5032
2	Zinzani PL, Magagnoli M, Pagliani G, et al: Primary intestinal lymphoma: clinical and therapeutic features of 32 patients. Haematologica. 82:305–308. 1997.
3	Koch P, del Valle F, Berdel WE, et al; German Multicenter Study Group. Primary gastrointestinal non-Hodgkin’s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol. 19:3861–3873. 2001.
4	DiSario JA, Burt RW, Vargas H and McWhorter WP: Small bowel cancer: epidemiological and clinical characteristics from a population-based registry. Am J Gastroenterol. 89:699–701. 1994.
5	Al-Mondhiry H: Primary lymphomas of the small intestine: east-west contrast. Am J Hematol. 22:89–105. 1986.
6	Salles G, Herbrecht R, Tilly H, et al: Aggressive primary gastrointestinal lymphomas: review of 91 patients treated with the LNH-84 regimen. A study of the Groupe d‘Etude des Lymphomes Agressifs. Am J Med. 90:77–84. 1991.
7	Rackner VL, Thirlby RC and Ryan JA Jr: Role of surgery in multimodality therapy for gastrointestinal lymphoma. Am J Surg. 161:570–575. 1991.
8	Shepherd FA, Evans WK, Kutas G, et al: Chemotherapy following surgery for stages IE and IIE non-Hodgkin’s lymphoma of the gastrointestinal tract. J Clin Oncol. 6:253–260. 1988.
9	Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, et al: Report of an international workshop to standardize response criteria for non-Hodgkin’s lymphomas. NCI Sponsored International Working Group. J Clin Oncol. 17:12441999.
10	Kaplan EL and Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:457–481. 1958.
11	Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 50:163–170. 1966.
12	Lee J, Kim WS, Kim K, et al: Intestinal lymphoma: exploration of the prognostic factors and the optimal treatment. Leuk Lymphoma. 45:339–344. 2004.
13	Gurney KA, Cartwright RA and Gilman EA: Descriptive epidemiology of gastrointestinal non-Hodgkin’s lymphoma in a population-based registry. Br J Cancer. 79:1929–1934. 1999.
14	Liang R, Todd D, Chan TK, Chiu E, Lie A, Kwong YL, et al: Prognostic factors for primary gastrointestinal lymphoma. Hematol Oncol. 13:153–163. 1995.
15	Radaszkiewicz T, Dragosics B and Bauer P: Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. Gastroenterology. 102:1628–1638. 1992.
16	Turowski GA and Basson MD: Primary malignant lymphoma of the intestine. Am J Surg. 169:433–441. 1995.
17	Daum S, Ullrich R, Heise W, et al: Intestinal non-Hodgkin’s lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin’s Lymphoma. J Clin Oncol. 21:2740–2746. 2003.
18	Ibrahim EM, Ezzat AA, El-Weshi AN, et al: Primary intestinal diffuse large B-cell non-Hodgkin’s lymphoma: clinical features, management, and prognosis of 66 patients. Ann Oncol. 12:53–58. 2001.
19	Kako S, Oshima K, Sato M, et al: Clinical outcome in patients with small-intestinal non-Hodgkin lymphoma. Leuk Lymphoma. 50:1618–1624. 2009.
20	Kim SJ, Kang HJ, Kim JS, et al: Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone. Blood. 117:1958–1965. 2011.